España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
SpringWorks Therapeutics
SWTX
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$35.59
0.81
2.33%
At close: -
$35.59
0.00
0.00%
After Hours: Dec 20, 4:01 PM EDT
Get Report
Comment
SpringWorks Therapeutics (SWTX) Forecast
News
Earnings
SpringWorks Therapeutics (SWTX) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Government Trades
Short Interest
Latest news for SpringWorks Therapeutics (NASDAQ:SWTX) Stock
SpringWorks Therapeutics Stock (NASDAQ: SWTX)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Wednesday, November 20, 2024
Evercore ISI Group Initiates Coverage On Spri...
Benzinga Newsdesk
Tuesday, November 12, 2024
HC Wainwright & Co. Maintains Buy on SpringWo...
Benzinga Newsdesk
SpringWorks Therapeutics shares are trading l...
Benzinga Newsdesk
SpringWorks Therapeutics' Cash, Cash Equivale...
Benzinga Newsdesk
SpringWorks Therapeutics Q3 2024 GAAP EPS $(0...
Benzinga Newsdesk
Earnings Scheduled For November 12, 2024
Benzinga Insights
Monday, November 11, 2024
SpringWorks Therapeutics To Present Mirdameti...
Benzinga Newsdesk
SpringWorks Unveils Results from Phase 2b Tri...
Benzinga Newsdesk
Thursday, November 07, 2024
SpringWorks Therapeutics Announced That Long-...
Benzinga Newsdesk
Wednesday, September 04, 2024
JP Morgan Maintains Overweight on SpringWorks...
Benzinga Newsdesk
Wednesday, August 28, 2024
HC Wainwright & Co. Reiterates Buy on SpringW...
Benzinga Newsdesk
SpringWorks Says European Medicines Agency Ha...
Benzinga Newsdesk
SpringWorks Therapeutics Says FDA Accepted Ne...
Benzinga Newsdesk
Thursday, August 08, 2024
SpringWorks Q2 Earnings Beat, Ogsiveo Drives Revenues
Zacks
Wednesday, August 07, 2024
SpringWorks Therapeutics shares are trading h...
Benzinga Newsdesk
SpringWorks Therapeutics Q2 2024 GAAP EPS $(0...
Benzinga Newsdesk
Monday, July 01, 2024
SpringWorks Therapeutics Has Completed The Su...
Benzinga Newsdesk
Friday, June 07, 2024
SpringWorks Therapeutics Inc Says Termination...
Benzinga Newsdesk
SpringWorks Therapeutics Says Termination Doe...
Benzinga Newsdesk
SpringWorks Therapeutics Says Deal Terminatio...
Benzinga Newsdesk
SpringWorks Therapeutics Got Notice Of Termin...
Benzinga Newsdesk
Tuesday, June 04, 2024
HC Wainwright & Co. Reiterates Buy on SpringW...
Benzinga Newsdesk
Friday, May 31, 2024
HC Wainwright & Co. Reiterates Buy on SpringW...
Benzinga Newsdesk
Monday, May 06, 2024
HC Wainwright & Co. Reiterates Buy on SpringW...
Benzinga Newsdesk
Thursday, May 02, 2024
SpringWorks shares are trading lower after th...
Benzinga Newsdesk
Springworks' Cash, Cash Equivalents And Marke...
Benzinga Newsdesk
SpringWorks Therapeutics Q1 2024 GAAP EPS $(1...
Benzinga Newsdesk
Wednesday, March 06, 2024
HC Wainwright & Co. Maintains Buy on SpringWo...
Benzinga Newsdesk
JP Morgan Maintains Overweight on SpringWorks...
Benzinga Newsdesk
Monday, March 04, 2024
SpringWorks Therapeutics Has Initiated A Roll...
Benzinga Newsdesk
Thursday, February 29, 2024
SpringWorks Therapeutics Announces European M...
Benzinga Newsdesk
Barclays Maintains Overweight on SpringWorks ...
Benzinga Newsdesk
Tuesday, February 27, 2024
SpringWorks Therapeutics shares are trading h...
Benzinga Newsdesk
SpringWorks Therapeutics: Q4 Earnings Insights
Benzinga Insights
SpringWorks Therapeutics Reported Q4 OGSIVEO ...
Benzinga Newsdesk
Monday, February 26, 2024
Wedbush Maintains Outperform on SpringWorks T...
Benzinga Newsdesk
Tuesday, February 20, 2024
SpringWorks Therapeutics shares are trading l...
Benzinga Newsdesk
Friday, February 16, 2024
SpringWorks Therapeutics shares are trading h...
Benzinga Newsdesk
Watching SpringWorks Therapeutics; Traders Ci...
Benzinga Newsdesk
Thursday, January 25, 2024
Barclays Maintains Overweight on SpringWorks ...
Benzinga Newsdesk
Friday, January 19, 2024
SpringWorks Therapeutics's Options Frenzy: What You Need to Know
Benzinga Insights
Tuesday, December 12, 2023
SpringWorks Therapeutics Option Alert: Jan 19...
Charles Gross
Tuesday, December 05, 2023
Why SpringWorks Therapeutics Stock (SWTX) Is Nosediving
Henry Khederian
SpringWorks Therapeutics Prices Upsized Publi...
Benzinga Newsdesk
Monday, December 04, 2023
SpringWorks Therapeutics Commences Public Off...
Benzinga Newsdesk
Thursday, November 30, 2023
Why Titan Machinery Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Lisa Levin
La-Z-Boy Posts Upbeat Earnings, Joins Victoria's Secret, Snowflake And Other Big Stocks Moving Higher On Thursday
Lisa Levin
Wednesday, November 29, 2023
SpringWorks Therapeutics shares are trading h...
Benzinga Newsdesk
Goldman Sachs Maintains Buy on SpringWorks Th...
Benzinga Newsdesk
Analyst Ratings for SpringWorks Therapeutics
Benzinga Insights
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch